These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 11070569)
41. The problem of compliance to cholesterol altering therapy. Insull W J Intern Med; 1997 Apr; 241(4):317-25. PubMed ID: 9159603 [TBL] [Abstract][Full Text] [Related]
43. Do statins confer early benefit after acute coronary syndromes? The results from FLORIDA. Varosy PD; Waters DD Eur Heart J; 2002 Dec; 23(24):1893-6. PubMed ID: 12473249 [No Abstract] [Full Text] [Related]
44. [Some economic considerations: the cost and rentability of rehabilitation]. Simorre R Soins Cardiol; 1983 May; (3):41-2. PubMed ID: 6412368 [No Abstract] [Full Text] [Related]
45. Prevention of coronary heart disease: is a cure too expensive? Cooke GA BMJ; 2004 Feb; 328(7436):405; author reply 405. PubMed ID: 14962888 [No Abstract] [Full Text] [Related]
46. [Medicalization of the coronary patient]. Jacobsen CD Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3119. PubMed ID: 7974440 [No Abstract] [Full Text] [Related]
47. What do we gain from the sixth coronary heart disease drug? Warburton RN BMJ; 2003 Nov; 327(7426):1237-8. PubMed ID: 14644934 [No Abstract] [Full Text] [Related]
48. Do hypolipidemic drugs lower medical expenses? Kauffman JM Pharmacotherapy; 2001 Dec; 21(12):1583-4; discussion 1584-6. PubMed ID: 11765310 [No Abstract] [Full Text] [Related]
49. The coronary spectrum. Managing the geriatric patient. Harris R J Rehabil; 1966; 32(2):98-100. PubMed ID: 5906559 [No Abstract] [Full Text] [Related]
50. Usefulness and hazards in the current and popular methods of treatment in cases of acute coronary episodes. TATUM AL Wis Med J; 1953 Sep; 52(9):533-4. PubMed ID: 13103110 [No Abstract] [Full Text] [Related]
51. Strategies to increase HMG-CoA reductase inhibitor use after acute myocardial infarction. Muhlestein JB Drugs Aging; 2004; 21(9):583-95. PubMed ID: 15260513 [TBL] [Abstract][Full Text] [Related]
52. Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. Li JJ; Chen MZ; Chen X; Fang CH Clin Cardiol; 2003 Oct; 26(10):472-6. PubMed ID: 14579918 [TBL] [Abstract][Full Text] [Related]
53. Pharmacoeconomics of lipid-lowering drugs. Smith DG Curr Atheroscler Rep; 2003 Jan; 5(1):67-72. PubMed ID: 12562545 [TBL] [Abstract][Full Text] [Related]
54. Drug insight: Statin use in the elderly. Raffel OC; White HD Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010 [TBL] [Abstract][Full Text] [Related]
55. The use over time of statins in coronary patients in an Italian tertiary referral center. Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871 [TBL] [Abstract][Full Text] [Related]
56. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle]. Savonitto S; Klugmann S Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860 [TBL] [Abstract][Full Text] [Related]
57. The role of statins in acute coronary syndromes: managing the unmet need. Jackson G Int J Clin Pract; 2000 Sep; 54(7):445-9. PubMed ID: 11070569 [TBL] [Abstract][Full Text] [Related]
58. Early statin therapy in acute coronary syndromes. Kinlay S; Ganz P Semin Vasc Med; 2003 Nov; 3(4):419-24. PubMed ID: 15199449 [TBL] [Abstract][Full Text] [Related]